Enterprise Value
43.3M
Cash
16.51M
Avg Qtr Burn
-8.866M
Short % of Float
3.18%
Insider Ownership
39.16%
Institutional Own.
4.50%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PDUFA Approval decision | ||
Phase 3 Data readout | ||
NRX-101 Details Bipolar depression, Acute Suicidal Ideation and Behavior | Phase 3 Data readout | |
NRX-100 (Ketamine Hydrochloride) Details Bipolar depression, Acute Suicidal Ideation and Behavior | Phase 3 Initiation | |
NRX-101 Details Acute Suicidal Ideation and Behavior, Bipolar depression | Phase 2/3 Data readout | |
NRX-101 Details Post-traumatic stress disorder | Phase 2 Data readout | |
BRILIFE Details COVID-19 | Failed Discontinued |